Lv21
130 积分 2024-06-25 加入
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions—Part 2
59分钟前
求助中
Targeted Radiopharmaceutical Therapy: Advances, Investment Dynamics, and Future Directions—Part 1
59分钟前
求助中
Phase 1 Dose-Escalation Study of [ 225 Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry
10天前
已关闭
Development and preclinical evaluation of NYM074 as a novel Theranostic ligand targeting carbonic anhydrase IX in renal cell carcinoma
10天前
已完结
Toxicity and dosimetry of177Lu-DOTA-Y3-octreotate in a rat model
13天前
已完结
Phase 1 Dose-Escalation Study of [ 225 Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry
16天前
已关闭
Evaluation of the safety, biodistribution, dosimetry of [18F]AlF-NYM005 and initial experience in clear cell renal cell carcinoma: an interim analysis of a prospective trial
22天前
已完结
Phase 1 Dose-Escalation Study of [ 225 Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry
22天前
已完结
Phase 1 Dose-Escalation Study of [ 225 Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry
24天前
已关闭
Sodium-iodide symporter (NIS)-mediated accumulation of [211At]astatide in NIS-transfected human cancer cells
1个月前
已关闭
皖公网安备34019202002308
